U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation

Molecular Cell

Volumn 62, Issue 4, 2016, Pages 479-490

  Park, Sung Mi ^a,b   Ou, Jianhong ^b   Chamberlain, Lynn ^a,b   Simone, Tessa M ^a,b   Yang, Huan ^a,b   Virbasius, Ching Man ^a,b   Ali, Abdullah M ^c   Zhu, Lihua Julie ^b   Mukherjee, Siddhartha ^c   Raza, Azra ^c   Green, Michael R ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOPHAGY RELATED FACTOR 7 PROTEIN; AZACITIDINE; ETOPOSIDE; INTERLEUKIN 3; MESSENGER RNA PRECURSOR; PROTEIN; PROTEIN P62; TOPOTECAN; UNCLASSIFIED DRUG; ATG7 PROTEIN, HUMAN; ATG7 PROTEIN, MOUSE; AUTOPHAGY RELATED PROTEIN 7; MESSENGER RNA; RNA PRECURSOR; SPLICING FACTOR U2AF; U2AF1 PROTEIN, HUMAN; U2AF1 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; GENOMIC INSTABILITY; HEMATOPOIETIC CELL; IMMUNOPRECIPITATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATION; MYELODYSPLASTIC SYNDROME; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; POLYADENYLATION; PROTEIN CLEAVAGE; REAL TIME POLYMERASE CHAIN REACTION; RNA PROCESSING; SPONTANEOUS MUTATION; X IRRADIATION; ACUTE MYELOID LEUKEMIA; AGED; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; NUDE MOUSE; PATHOLOGY; RNA 3' END PROCESSING; RNA INTERFERENCE; TIME FACTOR; TRANSFORMED CELL LINE; TUMOR VOLUME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 7; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MITOCHONDRIA; MUTATION; MYELODYSPLASTIC SYNDROMES; POLYADENYLATION; RNA 3' END PROCESSING; RNA INTERFERENCE; RNA PRECURSORS; RNA, MESSENGER; SPLICING FACTOR U2AF; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 84966660727     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2016.04.011     Document Type: Article

References (54)

1. Barrett L.W., Fletcher S., Wilton S.D. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell. Mol. Life Sci. 2012, 69:3613-3634.
2. Bjørkøy G., Lamark T., Pankiv S., Øvervatn A., Brech A., Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009, 452:181-197.
3. Brooks A.N., Choi P.S., de Waal L., Sharifnia T., Imielinski M., Saksena G., Pedamallu C.S., Sivachenko A., Rosenberg M., Chmielecki J., et al. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS ONE 2014, 9:e87361.
4. Comprehensive molecular portraits of human Networkbreast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
5. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013, 368:2059-2074. Cancer Genome Atlas Research Network.
6. Cazzola M., Rossi M., Malcovati L. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood 2013, 121:260-269. Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.
7. Daley G.Q., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA 1988, 85:9312-9316.
8. de Vries H., Rüegsegger U., Hübner W., Friedlein A., Langen H., Keller W. Human pre-mRNA cleavage factor II(m) contains homologs of yeast proteins and bridges two other cleavage factors. EMBO J. 2000, 19:5895-5904.
9. Elkon R., Ugalde A.P., Agami R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 2013, 14:496-506.
10. Ellis M.J., Ding L., Shen D., Luo J., Suman V.J., Wallis J.W., Van Tine B.A., Hoog J., Goiffon R.J., Goldstein T.C., et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360.
11. Feldman M.E., Apsel B., Uotila A., Loewith R., Knight Z.A., Ruggero D., Shokat K.M. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009, 7:e38.
12. Fleming A., Noda T., Yoshimori T., Rubinsztein D.C. Chemical modulators of autophagy as biological probes and potential therapeutics. Nat. Chem. Biol. 2011, 7:9-17.
13. Fu Y., Sun Y., Li Y., Li J., Rao X., Chen C., Xu A. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 2011, 21:741-747.
14. Furney S.J., Pedersen M., Gentien D., Dumont A.G., Rapinat A., Desjardins L., Turajlic S., Piperno-Neumann S., de la Grange P., Roman-Roman S., et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 2013, 3:1122-1129.
15. Gewirtz D.A. An autophagic switch in the response of tumor cells to radiation and chemotherapy. Biochem. Pharmacol. 2014, 90:208-211.
16. Graubert T.A., Shen D., Ding L., Okeyo-Owuor T., Lunn C.L., Shao J., Krysiak K., Harris C.C., Koboldt D.C., Larson D.E., et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. 2011, 44:53-57.
17. Gruber A.R., Martin G., Keller W., Zavolan M. Cleavage factor Im is a key regulator of 3' UTR length. RNA Biol. 2012, 9:1405-1412.
18. Harbour J.W., Roberson E.D., Anbunathan H., Onken M.D., Worley L.A., Bowcock A.M. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. 2013, 45:133-135.
19. Imielinski M., Berger A.H., Hammerman P.S., Hernandez B., Pugh T.J., Hodis E., Cho J., Suh J., Capelletti M., Sivachenko A., et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012, 150:1107-1120.
20. Ji Z., Lee J.Y., Pan Z., Jiang B., Tian B. Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl. Acad. Sci. USA 2009, 106:7028-7033.
21. Kim E., Ilagan J.O., Liang Y., Daubner G.M., Lee S.C., Ramakrishnan A., Li Y., Chung Y.R., Micol J.B., Murphy M.E., et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 2015, 27:617-630.
22. Klaunig J.E., Kamendulis L.M., Hocevar B.A. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 2010, 38:96-109.
23. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
24. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169:425-434.
25. Kralovicova J., Knut M., Cross N.C., Vorechovsky I. Identification of U2AF(35)-dependent exons by RNA-seq reveals a link between 3' splice-site organization and activity of U2AF-related proteins. Nucleic Acids Res. 2015, 43:3747-3763.
26. Liu H., He Z., von Rütte T., Yousefi S., Hunger R.E., Simon H.U. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci. Transl. Med. 2013, 5:202ra123.
27. Lundberg A.S., Randell S.H., Stewart S.A., Elenbaas B., Hartwell K.A., Brooks M.W., Fleming M.D., Olsen J.C., Miller S.W., Weinberg R.A., Hahn W.C. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 2002, 21:4577-4586.
28. Makishima H., Visconte V., Sakaguchi H., Jankowska A.M., Abu Kar S., Jerez A., Przychodzen B., Bupathi M., Guinta K., Afable M.G., et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012, 119:3203-3210.
29. Mansouri L., Grabowski P., Degerman S., Svenson U., Gunnarsson R., Cahill N., Smedby K.E., Geisler C., Juliusson G., Roos G., Rosenquist R. Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. Am. J. Hematol. 2013, 88:647-651.
30. Masamha C.P., Xia Z., Yang J., Albrecht T.R., Li M., Shyu A.B., Li W., Wagner E.J. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 2014, 510:412-416.
31. Mathew R., White E. Why sick cells produce tumors: the protective role of autophagy. Autophagy 2007, 3:502-505.
32. Mathew R., Kongara S., Beaudoin B., Karp C.M., Bray K., Degenhardt K., Chen G., Jin S., White E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007, 21:1367-1381.
33. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
34. Millevoi S., Loulergue C., Dettwiler S., Karaa S.Z., Keller W., Antoniou M., Vagner S. An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. EMBO J. 2006, 25:4854-4864.
35. Mizushima N., Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007, 3:542-545.
36. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
37. Mortensen M., Soilleux E.J., Djordjevic G., Tripp R., Lutteropp M., Sadighi-Akha E., Stranks A.J., Glanville J., Knight S., Jacobsen S.E., et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 2011, 208:455-467.
38. Papaemmanuil E., Cazzola M., Boultwood J., Malcovati L., Vyas P., Bowen D., Pellagatti A., Wainscoat J.S., Hellstrom-Lindberg E., Gambacorti-Passerini C., et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N. Engl. J. Med. 2011, 365:1384-1395. Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium.
39. Prasad J., Colwill K., Pawson T., Manley J.L. The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Mol. Cell. Biol. 1999, 19:6991-7000.
40. Przychodzen B., Jerez A., Guinta K., Sekeres M.A., Padgett R., Maciejewski J.P., Makishima H. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood 2013, 122:999-1006.
41. Quesada V., Ramsay A.J., Lopez-Otin C. Chronic lymphocytic leukemia with SF3B1 mutation. N. Engl. J. Med. 2012, 366:2530.
42. Shao C., Yang B., Wu T., Huang J., Tang P., Zhou Y., Zhou J., Qiu J., Jiang L., Li H., et al. Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genome. Nat. Struct. Mol. Biol. 2014, 21:997-1005.
43. Shi Y. Alternative polyadenylation: new insights from global analyses. RNA 2012, 18:2105-2117.
44. Thol F., Kade S., Schlarmann C., Löffeld P., Morgan M., Krauter J., Wlodarski M.W., Kölking B., Wichmann M., Görlich K., et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012, 119:3578-3584.
45. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
46. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
47. Vagner S., Vagner C., Mattaj I.W. The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. Genes Dev. 2000, 14:403-413.
48. Visconte V., Makishima H., Maciejewski J.P., Tiu R.V. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 2012, 26:2447-2454.
49. Wang L., Lawrence M.S., Wan Y., Stojanov P., Sougnez C., Stevenson K., Werner L., Sivachenko A., DeLuca D.S., Zhang L., et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 2011, 365:2497-2506.
50. Watson A.S., Mortensen M., Simon A.K. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia. Cell Cycle 2011, 10:1719-1725.
51. Yoshida K., Sanada M., Shiraishi Y., Nowak D., Nagata Y., Yamamoto R., Sato Y., Sato-Otsubo A., Kon A., Nagasaki M., et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.
52. Zamore P.D., Green M.R. Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc. Natl. Acad. Sci. USA 1989, 86:9243-9247.
53. Zhang J., Randall M.S., Loyd M.R., Dorsey F.C., Kundu M., Cleveland J.L., Ney P.A. Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation. Blood 2009, 114:157-164.
54. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.